Pesquisar
IO Biotech Inc
IOBTAdicionar à lista de desejos
0.048USD
0.0000.00%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
366.94KValor de mercado
PerdaP/L TTM
Mais detalhes de IO Biotech Inc Empresa
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Informações de IO Biotech Inc
Código da empresaIOBT
Nome da EmpresaIO Biotech Inc
Data de listagemNov 05, 2021
CEOZocca (Mai-Britt)
Número de funcionários80
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 05
EndereçoOle Maaloes Veh 3
CidadeCOPENHAGEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísDenmark
Código postal2200
Telefone4570702980
Sitehttps://www.iobiotech.com/
Código da empresaIOBT
Data de listagemNov 05, 2021
CEOZocca (Mai-Britt)
Executivos da empresa IO Biotech Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Mr. David V. Smith
Mr. David V. Smith
Independent Director
Independent Director
--
--
Mr. Brian Burkavage
Mr. Brian Burkavage
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
--
--
Ms. Amy B. Sullivan
Ms. Amy B. Sullivan
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Dr. Qasim Ahmad, M.D.
Dr. Qasim Ahmad, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Mai-Britt Zocca, Ph.D.
Dr. Mai-Britt Zocca, Ph.D.
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
76.47K
--
Mr. Devin Whittemore Smith
Mr. Devin Whittemore Smith
General Counsel, Company Secretary
General Counsel, Company Secretary
16.93K
+70.87%
Ms. Heidi Hunter
Ms. Heidi Hunter
Independent Director
Independent Director
15.00K
--
Dr. Peter Hirth, Ph.D.
Dr. Peter Hirth, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Christian E. Elling, Ph.D.
Dr. Christian E. Elling, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kathleen Sereda Glaub
Ms. Kathleen Sereda Glaub
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de IO Biotech Inc?
Os cinco principais acionistas de IO Biotech Inc são: Dr. Mai-Britt Zocca, Ph.D.
Quantas instituições possuem ações da IO Biotech Inc (IOBT)?
Em 2026Q1, 56 instituições possuíam ações da IO Biotech Inc, com valor de mercado aproximado de 33.96M, representando 47.71% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -19145442.00.